Kooper 6 weeks after stem cells! – Video
November 25th, 2012 8:45 am
Kooper 6 weeks after stem cells!
KooperFrom:KrystleCreleyViews:3 0ratingsTime:00:09More inComedy
Read more:
Kooper 6 weeks after stem cells! - Video
All You Need To Know About Stem Cells YouTube – Video
November 25th, 2012 8:45 am
All You Need To Know About Stem Cells YouTube
From:SAMIRA HALLAKViews:0 0ratingsTime:07:53More inPeople Blogs
More here:
All You Need To Know About Stem Cells YouTube - Video
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 1) – Video
November 25th, 2012 8:45 am
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 1)
Gynaecology Consultant Dr Madhuravally Thampi (TM Medical Centre) speaking on Stem Cells in Asianet Channel.(Part 1)From:TMMedicalCentreViews:0 0ratingsTime:12:34More inScience Technology
See the article here:
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 1) - Video
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 2) – Video
November 25th, 2012 8:45 am
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 2)
Gynaecology Consultant Dr Madhuravally Thampi (TM Medical Centre) speaking on Stem Cells in Asianet Channel.(Part 2)From:TMMedicalCentreViews:0 0ratingsTime:10:52More inScience Technology
View post:
Dr Madhuravally Thampi on Stem Cells (gynaecology) in Asianet Suprabhatam (Part 2) - Video
Blood Stem Cells – Three cases of dogs paralysed because of slipped disc – Video
November 25th, 2012 8:45 am
Blood Stem Cells - Three cases of dogs paralysed because of slipped disc
Three cases of dogs paralysed because of slipped disc, in which stem cells were used twice after surgery. The first case is a 12 year old rottweiller with slipped disc paralysis, the owner had him operated on successfully, but after three good months the dog began to worsen to the point that he could no longer get up or turn around when he was lying down. The owner was desperate because he knew he should have the dog put down for humanitarian reasons, so, overcoming his sadness, arranged the visit to the vet. When he arrived there he could not find parking so decided to return another day. That evening he heard about my treatment and the next day he brought the dog to me. We decided to treat him with stem cells even if there was little hope. When he arrived he could hardly walk and in the first video you see him 15 days after the first treatment. The owner was happy because the dog could turn, get up alone and walked better. We continued our therapeutic protocol and after 8 months the rottweiller was back to a normal life and even tried to run. The second case is a small bitch who had an emergency operation, by an excellent surgeon, for a slipped disc when her hindquarters were completely paralysed. After surgery she reacquired deep feeling, then she was able to stand on four legs for a few seconds and take a few uncoordinated steps. For 3 months there was a slight improvement but even though she had regular physiotherapy the dog regressed. The owner decided to try stem ...From:marcopolettiniengViews:1 0ratingsTime:10:12More inScience Technology
Continue reading here:
Blood Stem Cells - Three cases of dogs paralysed because of slipped disc - Video
ADN – Conscious Awakening – Video
November 25th, 2012 8:45 am
ADN - Conscious Awakening
You save the prison of flesh through visions of infinite, We now fathom the dash between frugile and intricit. So dive into it since our ancestors transgretions Span enter man #39;s quests for answers. Expand lectures, day dreams of foul wisdom, Transcending golden matrix control systems, Principals of business bring blisters to prisons Altering genes and jizz em without fear of reason So presume this, you #39;ve been lied to regrouven us Open up your eyes to the thighs the rulesness And true this you #39;ll get the true just of existence The flux of the sixth scent of physics for instance Multiplicity of? time and relativity of distance convince us We are one in the canvas regardless of the doses, Of lost forces the cosmosis in osmosis, Remain curious like most kids, Seeking visions of Moses on soul rifts. Superfluous beliefs systems condamn sets Values? They have themselves through Stem cells So stand clear and bang fear no end #39;s near #39;Cuz every form of life is a damn sphere We #39;re just a damn tear bound on plane by gravitation Absorbing mountain rain and levitation? Miracles of creation on a shit-shaped platter When shit shakes the ladder we shift shake? the matter Not one rig is random on all rings of Saturn Vibration is scattered by raw strings on patterns So gather yourself take my hand on this journey Through channels of wealth learning conscious yearning Cuz true creed, indeed, lies within the worthy Focus on our seed and unfold the story #39;Cuz we are one in the canvas ...From:terranu47Views:0 0ratingsTime:03:01More inMusic
Here is the original post:
ADN - Conscious Awakening - Video
Controversial Miracles stem cells – Video
November 25th, 2012 8:45 am
Controversial Miracles stem cells
From:Jay RhymeZ GodsentViews:1 0ratingsTime:07:58More inNonprofits Activism
Read more from the original source:
Controversial Miracles stem cells - Video
LUMINESCE™ Anti-Aging Serum – Buy LUMINESCE™ Online from Jeunesse – Video
November 25th, 2012 8:45 am
LUMINESCE trade; Anti-Aging Serum - Buy LUMINESCE trade; Online from Jeunesse
LUMINESCE trade; Cellular Rejuvenation Serum - Cyber Monday Online Shopping for Skincare, Beauty and Wellness Products antiagingskincareshoppe.com This Holidays Season, give the gift of improving overall wellness. Start with yourself. Be generous to your own well-being and share with others what you have discovered. It is never too earlier to start taking care of your body and your largest organ - your skin! Your skin is under constant attack by many factors you have little control over. The Jeunesse Youth Enhancement System uses DNA repair and antioxidant ingredients to improve cell performance and longevity. Our patent-pending Stem Cell Innovation helps generate new, vital skin cells in the first place. The skincare component of YES, LUMINESCE trade; super-charges the production of young, fresh skin cells. Infused with a potent growth factor complex derived from natural adult stem cells, the LUMINESCE trade; family of products rejuvenates skin cells at a molecular level. LUMINESCE trade; Cellular Rejuvenation Serum - Buy LUMINESCE trade; Online Order TODAY for a better you. antiagingskincareshoppe.com Happy Holidays 2012 from The Anti-Aging Skin Care ShoppeFrom:Scarlett Johnson RoseViews:1102 15ratingsTime:00:41More inPeople Blogs
See more here:
LUMINESCE™ Anti-Aging Serum - Buy LUMINESCE™ Online from Jeunesse - Video
ABC NEWS: Stem Cells Cure Blindness – Video
November 25th, 2012 8:42 am
ABC NEWS: Stem Cells Cure Blindness
ABC NEWS: Stem Cells Cure BlindnessFrom:stopevilViews:3 0ratingsTime:02:16More inNews Politics
Read the rest here:
ABC NEWS: Stem Cells Cure Blindness - Video
Introduction To Stem Cell Therapy For Parkinson’s And Alzheimer’s Diseases | Stem Cell Malaysia – Video
November 25th, 2012 8:41 am
Introduction To Stem Cell Therapy For Parkinson #39;s And Alzheimer #39;s Diseases | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy projects so much potential and hope for patients of different illnesses. This is due to the unique characteristics of stem cells. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:5 1ratingsTime:03:51More inPeople Blogs
Introducing Stem Cell Therapy Using Oral Placenta Stem Cells | Stem Cell Malaysia – Video
November 25th, 2012 8:41 am
Introducing Stem Cell Therapy Using Oral Placenta Stem Cells | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy can take on various forms and choices. Due to the advent of technology, stem cell therapy using oral placenta stem cells is now available. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:3 1ratingsTime:05:23More inScience Technology
See the article here:
Introducing Stem Cell Therapy Using Oral Placenta Stem Cells | Stem Cell Malaysia - Video
DWAH Stem Cell Therapy. – Video
November 25th, 2012 8:41 am
DWAH Stem Cell Therapy.
From:Dundas West AHViews:2 0ratingsTime:03:53More inPets Animals
Read more here:
DWAH Stem Cell Therapy. - Video
Perrin 410 Animal Hospital Stem Cell Therapy – Video
November 25th, 2012 8:41 am
Perrin 410 Animal Hospital Stem Cell Therapy
From:perrin410Views:0 0ratingsTime:09:58More inPets Animals
California Stem Cell Agency Still in Talks on $40 Million for StemCells, Inc.
November 25th, 2012 8:01 am
The California stem cell agency and
StemCells, Inc., are still trying to reach agreement on a deal in
which the company would receive $40 million from the state's
taxpayer-funded research effort.
The sticking point is the $40 million
in matching funds required from the Newark, Ca., firm under the terms
of the two awards approved in July and September. The latter award
was okayed on a 7-5 vote by the governing board after it was rejected
twice by the agency's reviewers.
in matching funds required from the Newark, Ca., firm under the terms
of the two awards approved in July and September. The latter award
was okayed on a 7-5 vote by the governing board after it was rejected
twice by the agency's reviewers.
On Monday the California Stem Cell
Report queried the agency about the status of the awards. Kevin
McCormack, the agency's spokesman, replied,
Report queried the agency about the status of the awards. Kevin
McCormack, the agency's spokesman, replied,
“We are still in talks with them over
the terms of the funding. Hopefully, we'll have an agreement soon.”
He did not elaborate further.
CIRM staff normally reviews
applications after they are approved by the agency's governing board
to be sure that all conditions are being met. However, in the case of
the September award to StemCells, Inc., CIRM's governing board took
the unusual step of publicly stating that the firm must demonstrate
it has the $20 million in matching funds before it receives any
payments from CIRM. The board did not take that sort of public
position on the $20 million grant approved earlier in the summer,
although matching funds are required in that case as well.
applications after they are approved by the agency's governing board
to be sure that all conditions are being met. However, in the case of
the September award to StemCells, Inc., CIRM's governing board took
the unusual step of publicly stating that the firm must demonstrate
it has the $20 million in matching funds before it receives any
payments from CIRM. The board did not take that sort of public
position on the $20 million grant approved earlier in the summer,
although matching funds are required in that case as well.
The former chairman of the $3 billion
stem cell agency, Robert Klein, appeared twice before the board to
lobby for approval of the second award to StemCells, Inc., which is a
publicly traded firm.. It was the first such appearance by Klein
before his former colleagues since leaving the agency in June 2011.
stem cell agency, Robert Klein, appeared twice before the board to
lobby for approval of the second award to StemCells, Inc., which is a
publicly traded firm.. It was the first such appearance by Klein
before his former colleagues since leaving the agency in June 2011.
Action on the StemCells, Inc., awards
attracted attention from the Los Angeles Times last month. Pulitzer
Prize-winning columnist Michael Hiltzik wrote that the process was “redolent of cronyism.” He said a “charmed relationship”
existed among StemCells, Inc., its “powerful friends” and the
stem cell agency.
attracted attention from the Los Angeles Times last month. Pulitzer
Prize-winning columnist Michael Hiltzik wrote that the process was “redolent of cronyism.” He said a “charmed relationship”
existed among StemCells, Inc., its “powerful friends” and the
stem cell agency.
Source:Texas Flap Looms Over California Stem Cell Agency’s Grant Appeals
November 25th, 2012 8:01 am
In nine days, the California stem cell
agency plans to take another crack at finding ways to curb its
free-wheeling appeal process involving scientists whose applications
for millions have been rejected by reviewers.
It is a matter of considerable interest
to researchers who need the cash to keep their labs running and remain in good standing with their host institutions.
to researchers who need the cash to keep their labs running and remain in good standing with their host institutions.
The stem cell agency's governing board this fall created a task force to deal with the appeals issue after a
record-breaking number of researchers made public appeals featuring
emotional patient advocates. Even the former chairman of the agency,
Robert Klein, made a two-time pitch for one applicant. Board members
later complained publicly about “arm-twisting,” lobbying and“emotionally charged presentations.”
record-breaking number of researchers made public appeals featuring
emotional patient advocates. Even the former chairman of the agency,
Robert Klein, made a two-time pitch for one applicant. Board members
later complained publicly about “arm-twisting,” lobbying and“emotionally charged presentations.”
The agenda for the Nov. 30 task force
meeting in Oakland -- with teleconferencing sites in San Francisco,
Irvine, Palo Alto, Seattle and Rochester, N.Y. -- contains few clues
on what the panel is hoping to specifically accomplish in next week's
90-minute session.
meeting in Oakland -- with teleconferencing sites in San Francisco,
Irvine, Palo Alto, Seattle and Rochester, N.Y. -- contains few clues
on what the panel is hoping to specifically accomplish in next week's
90-minute session.
But interested researchers can check
the transcript from the Oct. 24 meeting, during which CIRM President
Alan Trounson described the problem as “very critical.” He said,
the transcript from the Oct. 24 meeting, during which CIRM President
Alan Trounson described the problem as “very critical.” He said,
“I think this is a very serious
matter that could really bite us very hard in a similar way to what's
happened in Texas. Unless we come up with some kind of process that
really addresses the science, it's a very large concern.”
Trounson's Texas reference was to the
mass resignations of reviewers at that state's $3 billion cancer
research effort. Questions have been raised about integrity of its grant review process and the program's political and biotech industry
relationships. James Drew of the Dallas Morning News produced a bit of an overview this week. In another piece, Eric Berger of the
Houston Chronicle provided quotes from emails from the infighting on
a controversial $18 million grant.
mass resignations of reviewers at that state's $3 billion cancer
research effort. Questions have been raised about integrity of its grant review process and the program's political and biotech industry
relationships. James Drew of the Dallas Morning News produced a bit of an overview this week. In another piece, Eric Berger of the
Houston Chronicle provided quotes from emails from the infighting on
a controversial $18 million grant.
Changes in California's grant appeal process may well
be also discussed at the agency's board meeting Dec. 12 in Los Angeles.
The board hopes to wrap up its action by late January.
be also discussed at the agency's board meeting Dec. 12 in Los Angeles.
The board hopes to wrap up its action by late January.
Here is a link to an item with more specifics on material presented to the task force in October. Here is a link to an August 2012 list of articles and documents related to the CIRM appeals process.
Interested parties can address comments
to the agency at info@cirm.ca.gov.
to the agency at info@cirm.ca.gov.
Source:Pomeroy Moving On, Will Leave Stem Cell Board
November 25th, 2012 8:01 am
Claire Pomeroy, one of the longtime
members of the governing board of the $3 billion California stem cell agency,
will be leaving her position at UC Davis and the stem cell board next
June.
Pomeroy yesterday announced her departure from Davis as vice chancellor for human health services and
dean of the medical school. In a telephone interview, she told the
California Stem Cell Report that she is examining a “few select
opportunities” to work at a national level on health reform and
health policy issues.
dean of the medical school. In a telephone interview, she told the
California Stem Cell Report that she is examining a “few select
opportunities” to work at a national level on health reform and
health policy issues.
 |
| Claire Pomeroy UC Davis photo |
Pomeroy, 57, will be spending time in
Washington, D.C., working on health issues on behalf of the
University of California during the transition period before she
leaves her position in California.
Washington, D.C., working on health issues on behalf of the
University of California during the transition period before she
leaves her position in California.
Pomeroy came to UC Davis 10 years ago,
shortly before the Golden State's stem cell agency was created in
2004. At that time, UC Davis had what she called a “fledgling”
stem cell research effort. Today the school has chalked up $128 million in
grants from the stem cell agency, ranking fifth among institutions
funded by the agency.
shortly before the Golden State's stem cell agency was created in
2004. At that time, UC Davis had what she called a “fledgling”
stem cell research effort. Today the school has chalked up $128 million in
grants from the stem cell agency, ranking fifth among institutions
funded by the agency.
She said that creation of the stem cell
agency “catalyzed development of our program,” which she said has
risen to “national prominence.”
agency “catalyzed development of our program,” which she said has
risen to “national prominence.”
Pomeroy's service on the stem cell
agency board was also instrumental in attracting a $100 million grant
from the Moore Foundation to start a new school of nursing at UC
Davis in 2009. Through her service on the board, she met Ed Penhoet,
who also served on the board and was one of the co-founders of Chiron
and then president of the Moore Foundation. Subsequently, Penhoet
called her for lunch to discuss her thoughts on nursing education,
and developments moved on from there.
agency board was also instrumental in attracting a $100 million grant
from the Moore Foundation to start a new school of nursing at UC
Davis in 2009. Through her service on the board, she met Ed Penhoet,
who also served on the board and was one of the co-founders of Chiron
and then president of the Moore Foundation. Subsequently, Penhoet
called her for lunch to discuss her thoughts on nursing education,
and developments moved on from there.
The $100 million commitment was the
nation's largest grant for nursing education, according to the Moore Foundation.
nation's largest grant for nursing education, according to the Moore Foundation.
Source:‘The Knoepfler Award:’ Recognizing Risk and Those Who Make a Difference
November 25th, 2012 8:01 am
A UC Davis stem cell researcher-blogger has announced a “stem cell person of the year” award
complete with a $1,000 cash prize that he is putting up himself.
Paul Knoepfler, who may be the only
stem cell scientist in the U.S. actively blogging on the subject,
said he has decided to put his money where his mouth is.
stem cell scientist in the U.S. actively blogging on the subject,
said he has decided to put his money where his mouth is.
Since announcing the contest in a Nov.13 blog item, Knoepfler has already received eight nominations,
including one for a scientist. Three days after the item aappeared, UC Davis
featured Knoepfler in a press release that included a video of
Knoepfler explaining the effort.
including one for a scientist. Three days after the item aappeared, UC Davis
featured Knoepfler in a press release that included a video of
Knoepfler explaining the effort.
 |
| Paul Knoepfler UC Davis photo |
He said he wanted to go beyond “old
fashioned awards” given by “stodgy committees.” Knoepfler said he
is seeking to recognize that stem cell research is “transcending the
lab.”
The goal of the award, Knoepfler said,
is “to advance the stem cell field and give credit to those who
make a real difference.”
is “to advance the stem cell field and give credit to those who
make a real difference.”
Knoepfler wrote,
“The criteria are that the person
made a truly outstanding difference in the stem cell field for 2012.
The winner could be a scientist, a patient advocate, someone in
industry, a student, a physician…really anyone who has made the
field better. For non-scientist nominees I’m particularly
interested in those who took personal risks or gave of themselves to
help others. For scientists I am looking for outstanding scientific
achievement and in particular out-of-the-box thinking. Folks in any
country are eligible.”
Deadline for nominations is Dec. 17.
Self-nominations are permissible. Knoepfler plans to pick five
finalists and interview them by phone. He also plans an online vote
that he said “may” influence his decision.
Self-nominations are permissible. Knoepfler plans to pick five
finalists and interview them by phone. He also plans an online vote
that he said “may” influence his decision.
Complete details are available on Knoepfler's blog.
Source:California Stem Cell Agency Blogs on Geron Clinical Trial
November 25th, 2012 8:01 am
The California stem cell agency
published an article online last week concerning the hESC clinical
trial that Geron abandoned last year, dealing mainly with one of the
participants in the program.
The piece was studiously non-committal
about whether the $3 billion research program is likely to fund the
trial once again, should BioTime, Inc., of Alameda, Ca., be
successful in acquiring the assets of once was the first hESC
clinical trial in the United States. The agency loaned Geron $25
million a few months before the company cancelled the trial.
about whether the $3 billion research program is likely to fund the
trial once again, should BioTime, Inc., of Alameda, Ca., be
successful in acquiring the assets of once was the first hESC
clinical trial in the United States. The agency loaned Geron $25
million a few months before the company cancelled the trial.
Amy Adams, CIRM's communications
manager, simply wrote,
manager, simply wrote,
“They (BioTime) would need to apply
for a loan if they want CIRM to financially support the continued
trial.”
The latest round of funding that
BioTime could apply for has a deadline of Dec. 18 for letters of
intent. In addition to a loan, a grant is also a possibility.
BioTime could apply for has a deadline of Dec. 18 for letters of
intent. In addition to a loan, a grant is also a possibility.
Adams focused on Katie Sharify, who was
enrolled in the clinical trial shortly before Geron said it was
dropping the effort for financial reasons. Adams interviewed Sharify
before an audience of scientists.
enrolled in the clinical trial shortly before Geron said it was
dropping the effort for financial reasons. Adams interviewed Sharify
before an audience of scientists.
Adams wrote,
“Katie told me that it would be
impossible not to hope that a trial would help her, but that by the
time she made the decision to participate she knew she was doing it
to further science, not necessarily to further her own recovery. She
told the audience, 'I was part of something that was bigger than me,
and bigger than all of you.'”
Stem cell scientist Paul Knoepfler of
UC Davis also wrote about the BioTime-Geron deal last week. Noting
that Geron's decision a year ago left many “upset to put it
mildly,” Knoepfler said the “idea of BioTime buying the Geron
stem cell program is a great one that provides new hope on many
levels.”
UC Davis also wrote about the BioTime-Geron deal last week. Noting
that Geron's decision a year ago left many “upset to put it
mildly,” Knoepfler said the “idea of BioTime buying the Geron
stem cell program is a great one that provides new hope on many
levels.”
Source:Researcher Alert: Keeping Tabs on the Stem Cell Exchequer
November 25th, 2012 8:01 am
The California stem cell agency has
posted the dates for meetings of its board of directors for 2013
with most of the sessions scheduled for the San Francisco Bay Area.
One is expected to take place in San
Diego in August, and another in Los Angeles 13 months from now. The
other five are in Northern California. Not yet on the schedule is a board workshop in early January that will be open to the public.
Diego in August, and another in Los Angeles 13 months from now. The
other five are in Northern California. Not yet on the schedule is a board workshop in early January that will be open to the public.
Why is this of interest to researchers
and others? The board controls the purse strings to $3 billion for research grants and determines what areas are to be funded. Astute scientists would do well to take in the sessions.
They offer insights into board thinking and opportunities to deal
with the agency staff and directors on an informal basis. Only a
handful of researchers – or less – attend the meetings on a
regular basis, but have been well-served by the time spent.
and others? The board controls the purse strings to $3 billion for research grants and determines what areas are to be funded. Astute scientists would do well to take in the sessions.
They offer insights into board thinking and opportunities to deal
with the agency staff and directors on an informal basis. Only a
handful of researchers – or less – attend the meetings on a
regular basis, but have been well-served by the time spent.
Source:California Stem Cell Agency Still in Talks on $40 Million for StemCells, Inc.
November 25th, 2012 7:58 am
The California stem cell agency and
StemCells, Inc., are still trying to reach agreement on a deal in
which the company would receive $40 million from the state's
taxpayer-funded research effort.
The sticking point is the $40 million
in matching funds required from the Newark, Ca., firm under the terms
of the two awards approved in July and September. The latter award
was okayed on a 7-5 vote by the governing board after it was rejected
twice by the agency's reviewers.
in matching funds required from the Newark, Ca., firm under the terms
of the two awards approved in July and September. The latter award
was okayed on a 7-5 vote by the governing board after it was rejected
twice by the agency's reviewers.
On Monday the California Stem Cell
Report queried the agency about the status of the awards. Kevin
McCormack, the agency's spokesman, replied,
Report queried the agency about the status of the awards. Kevin
McCormack, the agency's spokesman, replied,
“We are still in talks with them over
the terms of the funding. Hopefully, we'll have an agreement soon.”
He did not elaborate further.
CIRM staff normally reviews
applications after they are approved by the agency's governing board
to be sure that all conditions are being met. However, in the case of
the September award to StemCells, Inc., CIRM's governing board took
the unusual step of publicly stating that the firm must demonstrate
it has the $20 million in matching funds before it receives any
payments from CIRM. The board did not take that sort of public
position on the $20 million grant approved earlier in the summer,
although matching funds are required in that case as well.
applications after they are approved by the agency's governing board
to be sure that all conditions are being met. However, in the case of
the September award to StemCells, Inc., CIRM's governing board took
the unusual step of publicly stating that the firm must demonstrate
it has the $20 million in matching funds before it receives any
payments from CIRM. The board did not take that sort of public
position on the $20 million grant approved earlier in the summer,
although matching funds are required in that case as well.
The former chairman of the $3 billion
stem cell agency, Robert Klein, appeared twice before the board to
lobby for approval of the second award to StemCells, Inc., which is a
publicly traded firm.. It was the first such appearance by Klein
before his former colleagues since leaving the agency in June 2011.
stem cell agency, Robert Klein, appeared twice before the board to
lobby for approval of the second award to StemCells, Inc., which is a
publicly traded firm.. It was the first such appearance by Klein
before his former colleagues since leaving the agency in June 2011.
Action on the StemCells, Inc., awards
attracted attention from the Los Angeles Times last month. Pulitzer
Prize-winning columnist Michael Hiltzik wrote that the process was “redolent of cronyism.” He said a “charmed relationship”
existed among StemCells, Inc., its “powerful friends” and the
stem cell agency.
attracted attention from the Los Angeles Times last month. Pulitzer
Prize-winning columnist Michael Hiltzik wrote that the process was “redolent of cronyism.” He said a “charmed relationship”
existed among StemCells, Inc., its “powerful friends” and the
stem cell agency.
Source: